The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline

Respiratory Medicine

Volumn 114, Issue , 2016, Pages 27-37

  Karch, Annika ^a   Vogelmeier, Claus ^b   Welte, Tobias ^a   Bals, Robert ^c   Kauczor, Hans Ulrich ^d   Biederer, Jürgen ^d   Heinrich, Joachim ^e   Schulz, Holger ^e   Gläser, Sven ^f   Holle, Rolf ^e   Watz, Henrik ^g   Korn, Stephanie ^h   Adaskina, Nina ^a   Biertz, Frank ^a   Vogel, Charlotte ^a   Vestbo, Jørgen ⁱ   Wouters, Emiel F M ^j   Rabe, Klaus Friedrich ^g   Söhler, Sandra ^k   Koch, Armin ^a   Jörres, Rudolf A ^l   more..

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^g GERMAN CENTER FOR LUNG RESEARCH   (Germany)

^h UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^k PHILIPPS UNIVERSITY MARBURG   (Germany)

^l LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

more..

Author keywords

Cohort; Comorbidity; COPD; Study design; Systemic inflammation

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY PLETHYSMOGRAPHY; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION; PREVALENCE; PRIORITY JOURNAL; SMOKING; SPIROMETRY; WALKING; COHORT ANALYSIS; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; FOLLOW UP; GERMANY; METABOLISM; OBSERVATIONAL STUDY; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84961774661     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.03.008     Document Type: Article

References (70)

1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional and national levels of age-specific mortality and 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 Lancet 2015 10.1016/S0140-6736(14)61682-2
2. D.M. Mannino, K. Higuchi, T.-C. Yu, H. Zhou, Y. Li, H. Tian, and et al. economic burden of chronic obstructive pulmonary disease by presence of comorbidities Chest 2015 10.1007/s00246-002-9361-x
3. J. Vestbo, L.D. Edwards, P.D. Scanlon, J.C. Yates, A. Agusti, P. Bakke, and et al. Changes in forced expiratory volume in 1 second over time in COPD N. Engl. J. Med. 365 2011 1184 1192 10.1056/NEJMoa1105482
4. A. Agusti, P.M.A. Calverley, B. Celli, H.O. Coxson, L.D. Edwards, D.A. Lomas, and et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort Respir. Res. 11 2010 122 10.1186/1465-9921-11-122
5. A. Gershon, and G. Mecredy Quantifying comorbidity in individuals with chronic obstructive pulmonary disease: A population study Eur. Respir. J. 2014 1 9 10.1183/09031936.00061414
6. L.E.G.W. Vanfleteren, M.A. Spruit, M. Groenen, S. Gaffron, V.P.M. Van Empel, P.L.B. Bruijnzeel, and et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 187 2013 728 735 10.1164/rccm.201209-1665OC
7. M.C. Smith, and J.P. Wrobel Epidemiology and clinical impact of major comorbidities in patients with COPD Int. J. COPD 9 2014 871 888
8. A. Cavaillès, G. Brinchault-Rabin, A. Dixmier, F. Goupil, C. Gut-Gobert, S. Marchand-Adam, and et al. Comorbidities of COPD Eur. Respir. Rev. 22 2013 454 475 10.1183/09059180.00008612
9. N.R. Anthonisen, M.A. Skeans, R.A. Wise, J. Manfreda, R.E. Kanner, J.E. Connett, and et al. The effects of a smoking cessation intervention on 14.5-year mortality Ann. Intern. Med. 142 2005 234 239
10. P.M.A. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, P.W. Jones, and et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N. Engl. J. Med. 356 2007 775 789 10.1056/NEJMoa063070
11. J. Vestbo, E. Prescott, T. Almdal, M. Dahl, B.G. Nordestgaard, T. Andersen, and et al. Body mass, fat free body mass and prognosis in COPD patients from a random population sample Am. J. Respir. Crit. Care Med. 173 2005 79 83 10.1164/rccm.200506-969OC
12. T. Ng, N. Mathew, W. Tan, Z. Cao, K. Ong, and P. Eng Depressive symptoms and chronic obstructive pulmonary disease Arch. Intern Med. 167 2007 60 67 10.1001/archinte.167.1.60
13. M. Sarkar, R. Bhardwaj, I. Madabhavi, and J. Khatana Osteoporosis in chronic obstructive pulmonary disease Clin. Med. Insights Circ. Respir. Pulm. Med. 9 2015 5 21 10.1183/09031936.03.00004609
14. A.E. Mirrakhimov Chronic obstructive pulmonary disease and glucose metabolism: A bitter sweet symphony Cardiovasc. Diabetol. 11 2012 132 10.1186/1475-2840-11-132
15. K.F. Rabe, and J.A. Wedzicha Controversies in treatment of chronic obstructive pulmonary disease Lancet 378 2011 1038 1047 10.1016/S0140-6736(11)61295-6
16. P.J. Barnes, and B.R. Celli Systemic manifestations and comorbidities of COPD Eur. Respir. J. 33 2009 1165 1185 10.1183/09031936.00128008
17. H. Magnussen, and H. Watz Systemic inflammation in chronic obstructive pulmonary disease and asthma: Relation with comorbidities Proc. Am. Thorac. Soc. 6 2009 648 651 10.1513/pats.200906-053DP
18. C.F. Vogelmeier, and E.F.M. Wouters Treating the systemic effects of chronic obstructive pulmonary disease Proc. Am. Thorac. Soc. 8 2011 376 379 10.1513/pats.201102-020RM
19. R. Holle, M. Happich, H. Löwel, and H. Wichmann KORA - A research platform for population based health research Das Gesundheitswes 67 2005 19 25 10.1055/s-2005-858235
20. A. Peters, A. Döring, K.-H. Ladwig, C. Meisinger, B. Linkohr, C. Autenrieth, and et al. Multimorbidity and successful aging Z. Gerontol. Geriatr. 44 2011 41 54 10.1007/s00391-011-0245-7
21. U. John, B. Greiner, E. Hensel, J. Lüdemann, M. Piek, S. Sauer, and et al. Study of health in pomerania(SHIP): A health examination survey in an east German region: Objectives and design Soz Praventivmed 46 2001 186 194
22. H. Völzke, D. Alte, C.O. Schmidt, D. Radke, R. Lorbeer, N. Friedrich, and et al. Cohort profile: The study of health in pomerania Int. J. Epidemiol. 40 2011 294 307 10.1093/ije/dyp394
23. B.R. Celli, B.R. Celli, C.G. Cote, C.G. Cote, J.M. Marin, J.M. Marin, and et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N. Engl. J. Med. 2004 1005 1012
24. C.G. Cote, and B.R. Celli Pulmonary rehabilitation and the BODE index in COPD Eur. Respir. J. 26 2005 630 636 10.1183/09031936.05.00045505
25. F.W.S. Ko, W. Tam, A.H.M. Tung, J. Ngai, S.S.S. Ng, K. Lai, and et al. A longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD Respir. Med. 105 2011 266 273 10.1016/j.rmed.2010.06.022
26. D.A. Lynch, H.M. Austin, J.C. Hogg, P.A. Grenier, H.-U. Kauczor, A.A. Bankier, and et al. CT-definable subtypes of chronic obstructive pulmonary disease: A statement of the fleischner society Radiology 277 2015 192 205 10.1148/radiol.2015141579
27. M. Bryant, S. Ley, R. Eberhardt, R. Menezes, F. Herth, O. Sedlaczek, and et al. Assessment of the relationship between morphological emphysema phenotype and corresponding pulmonary perfusion pattern on a segmental level Eur. Radiol. 25 2014 72 80 10.1007/s00330-014-3385-5
28. R.A. Jörres, T. Welte, R. Bals, A. Koch, M. Schnoor, and C. Vogelmeier Einfluss systemischer Manifestationen und Komorbiditäten auf den klinischen Zustand und den Verlauf bei COPD: Eine Übersicht über die Kohortenstudie COSYCONET Dtsch. Med. Wochenschr. 135 2010 446 449 10.1055/s-0030-1249185
29. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015 http://www.goldcopd.org/
30. P.H. Quanjer, S. Stanojevic, T.J. Cole, X. Baur, G.L. Hall, B.H. Culver, and et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: The global lung function 2012 equations Eur. Respir. J. 40 2012 1324 1343 10.1183/09031936.00080312
31. B. Koch, N. Friedrich, H. Völzke, R.A. Jörres, S.B. Felix, R. Ewert, and et al. Static lung volumes and airway resistance reference values in healthy adults Respirology 18 2013 170 178 10.1111/j.1440-1843.2012.02268.x
32. J.E. Cotes, D.J. Chinn, P.H. Quanjer, and J. Roca, J.-C. Yernault Standardization of the measurement of transfer factor (diffusing capacity) Eur. Respir. J. 6 1993 41 52
33. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, and et al. Standardisation of spirometry Eur. Respir. J. 26 2005 319 338
34. C. Criée, D. Berdel, D. Heise, P. Kardos, D. Köhler, W. Leupold, and et al. Empfehlungen der Deutschen Atemwegsliga zur Spirometrie Pneumologie 60 2006 576 584
35. J. Wanger, J.L. Clausen, A. Coates, O.F. Pedersen, V. Brusasco, F. Burgos, and et al. Standardisation of the measurement of lung volumes Eur. Respir. J. 26 2005 511 522
36. C.P. Criée, S. Sorichter, H.J. Smith, P. Kardos, R. Merget, D. Heise, and et al. Body plethysmography-its principles and clinical use Respir. Med. 105 2011 959 971 10.1016/j.rmed.2011.02.006
37. N. MacIntyre, R.O. Crapo, G. Viegi, D.C. Johnson, C.P.M. van der Grinten, V. Brusasco, and et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur. Respir. J. 26 2005 720 735
38. U.G. Kyle, I. Bosaeus, A.D. De Lorenzo, P. Deurenberg, M. Elia, J. Manuel Gómez, and et al. Bioelectrical impedance analysis-part II: Utilization in clinical practice Clin. Nutr. 23 2004 1430 1453 10.1016/j.clnu.2004.09.012
39. C. Diehm, H. Darius, D. Pittrow, and J.R. Allenberg Knöchel-arm-index Dtsch. Arztebl. 102 2005 2310 2314
40. D. Podsiadlo, and S. Richardson The timed "Up & Go": A test of basic functional mobility for frail elderly persons J. Am. Geriatr. Soc. 39 1991 142 148
41. R.O. Crapo, R. Casaburi, A.L. Coates, P.L. Enright, N.R. MacIntyre, R.T. McKay, and et al. ATS statement: Guidelines for the six-minute walk test Am. J. Respir. Crit. Care Med. 166 2002 111 117
42. M. Meguro, E.A. Barley, S. Spencer, and P.W. Jones Development and validation of an improved, COPD-specific version of the St. George respiratory questionnaire Chest 132 2007 456 463 10.1378/chest.06-0702
43. P.W. Jones, G. Harding, P. Berry, I. Wiklund, W.H. Chen, and N. Kline Leidy Development and first validation of the COPD assessment test Eur. Respir. J. 34 2009 648 654
44. K. Kroenke, R.L. Spitzer, and J.B.W. Williams The PHQ-9: Validity of a brief depression severity measure J. Gen. Intern. Med. 16 2001 606 613
45. E. Kalbe, J. Kessler, P. Calabrese, R. Smith, A.P. Passmore, M. Brand, and et al. DemTect: A new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia Int. J. Geriatr. Psychiatr. 19 2004 136 143 10.1002/gps.1042
46. C.L. Craig, A.L. Marshall, M. Sjöström, A.E. Bauman, M.L. Booth, B.E. Ainsworth, and et al. International physical activity questionnaire: 12-Country reliability and validity Med. Sci. Sports Exerc. 35 2003 1381 1395
47. M. Nonnemacher, D. Weiland, and J. Stausberg Datenqualität in der medizinischen Forschung - Leitlinie zum adaptiven Management von Datenqualität in Kohortenstudien und Registern 2007 MWV Medizinisch Wissenschaftliche Verlagsgesellschaft Berlin
48. S. Karrasch, C. Flexeder, J. Behr, R. Holle, R.M. Huber, R.A. Jörres, and et al. Spirometric reference values for advanced age from a South German population Respiration 85 2013 210 219
49. E. Albrecht, E. Sillanpää, S. Karrasch, A.C. Alves, V. Codd, I. Hovatta, and et al. Telomere length in circulating leukocytes is associated with lung function and disease Eur. Respir. J. 43 2014 983 992 http://www.ncbi.nlm.nih.gov/pubmed/24311771
50. S. Glaser, T. Ittermann, B. Koch, H. Volzke, H. Wallaschofski, M. Nauck, and et al. Airflow limitation, lung volumes and systemic inflammation in a general population Eur. Respir. J. 39 2012 29 37 10.1183/09031936.00009811
51. S. Gläser, C. Schäper, A. Obst, T. Ittermann, H. Völzke, S.B. Felix, and et al. Impact of different definitions of airflow limitation on the prevalence of chronic obstructive pulmonary disease in the general population Respiration 80 2010 292 300 10.1159/000282171
52. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2001 http://www.goldcopd.org/
53. R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, and S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary Am. J. Respir. Crit. Care Med. 163 2001 1256 1276 10.1164/ajrccm.163.5.2101039
54. B. Gjerde, P.S. Bakke, T. Ueland, J.A. Hardie, and T.M.L. Eagan The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway Respir. Med. 106 2012 361 366 10.1016/j.rmed.2011.10.004
55. T.M.L. Eagan, T. Ueland, P.D. Wagner, J.A. Hardie, T.E. Mollnes, J.K. Damås, and et al. Systemic inflammatory markers in COPD: Results from the Bergen COPD Cohort Study Eur. Respir. J. 35 2010 540 548 10.1183/09031936.00088209
56. L.J.P. Persson, M. Aanerud, P.S. Hiemstra, J.A. Hardie, P.S. Bakke, and T.M.L. Eagan Chronic obstructive pulmonary disease is associated with low levels of vitamin D PLoS One 7 2012 10.1371/journal.pone.0038934
57. P.R. Burgel, R. Escamilla, T. Perez, P. Carré, D. Caillaud, P. Chanez, and et al. Impact of comorbidities on COPD-specific health-related quality of life Respir. Med. 107 2013 233 241 10.1016/j.rmed.2012.10.002
58. J. Bourbeau, W.C. Tan, A. Benedetti, S.D. Aaron, K.R. Chapman, H.O. Coxson, and et al. Canadian cohort obstructive lung disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD COPD J. Chronic Obstr. Pulm. Dis. 2555 2012 10.3109/15412555.2012.665520 120320071926007
59. W.C. Tan, D.D. Sin, J. Bourbeau, P. Hernandez, K.R. Chapman, R. Cowie, and et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: Results from the CanCOLD study (supplement) Thorax 70 2015 822 829 10.1136/thoraxjnl-2015-206938
60. M.K. Han, H. Muellerova, D. Curran-Everett, M.T. Dransfield, G.R. Washko, E.A. Regan, and et al. GOLD 2011 disease severity classification in COPDGene: A prospective cohort study (supplement) Lancet Respir. Med. 1 2013 43 50 10.1016/S2213-2600(12)70044-9
61. M. Nishimura, H. Makita, K. Nagai, S. Konno, Y. Nasuhara, M. Hasegawa, and et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 185 2012 44 52 10.1164/rccm.201106-0992OC
62. M. Suzuki, Y. Torii, J. Kawada, H. Kimura, H. Kamei, Y. Onishi, and et al. Immunogenicity of inactivated seasonal influenza vaccine in adult and pediatric liver transplant recipients over two seasons Microbiol. Immunol. 57 2013 715 722 10.1111/1348-0421.12086
63. G.C. Donaldson, M. Law, B. Kowlessar, R. Singh, S.E. Brill, J.P. Allinson, and et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 192 2015 943 950 10.1164/rccm.201412-2269OC
64. A.R.C. Patel, G.C. Donaldson, A.J. Mackay, J.A. Wedzicha, and J.R. Hurst The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD Chest 141 2012 851 857 10.1378/chest.11-0853
65. A. Jochmann, A. Scherr, D.C. Jochmann, D. Miedinger, S.S. Török, P.N. Chhajed, and et al. Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort Swiss Med. Wkly. 142 2012 1 11 10.4414/smw.2012.13567
66. J. Vestbo, and P. Lange Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med. 166 2002 329 332 10.1164/rccm.2112048
67. P.M.A. Calverley The GOLD classification has advanced understanding of COPD Am. J. Respir. Crit. Care Med. 170 2004 211 212 10.1164/rccm.2405008
68. H.H.M. Kerstjens The GOLD classification has not advanced understanding of COPD Am. J. Respir. Crit. Care Med. 170 2004 212 213 10.1164/rccm.2405008
69. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006 http://www.goldcopd.org/
70. M.R. Maleki-Yazdi, C.K. Lewczuk, J.M. Haddon, N. Choudry, and N. Ryan Early detection and impaired quality of life in COPD GOLD stage 0: A pilot study COPD 4 2007 313 320 10.1080/15412550701595740